Literature DB >> 36105746

Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice.

Pulak R Nath1,2, Dipasmita Pal-Nath1, Sukhbir Kaur1, Arunkumar Gangaplara3, Thomas J Meyer4, Margaret C Cam4, David D Roberts1.   

Abstract

CD47 has established roles in the immune system for regulating macrophage phagocytosis and lymphocyte activation, with growing evidence of its cell-intrinsic regulatory roles in natural killer and CD8+ T cells. CD47 limits antigen-dependent cytotoxic activities of human and murine CD8+ T cells, but its role in T cell activation kinetics remains unclear. Using in vitro and in vivo models, we show here that CD47 differentially regulates CD8+ T cell responses to short- versus long-term activation. Although CD47 was not required for T cell development in mice and early activation in vitro, short-term stimuli elevated pathogen-reactive gene expression and enhanced proliferation and the effector phenotypes of Cd47-deficient relative to Cd47-sufficient CD8+ T cells. In contrast, persistent TCR stimulation limited the effector phenotypes of Cd47 -/- CD8+ T cells and enhanced their apoptosis signature. CD8+ T cell expansion and activation in vivo induced by acute lymphocytic choriomeningitis virus (LCMV) infection did not differ in the absence of CD47. However, the frequency and effector phenotypes of Cd47-/- CD8+ T cells were constrained in chronic LCMV-infected as well as in mice bearing B16 melanoma tumors. Therefore, CD47 regulates CD8+ T cell activation, proliferation, and fitness in a context-dependent manner. This work was authored as part of the Contributor’s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 USC 105, no copyright protection is available for such works under US Law.

Entities:  

Keywords:  CD47; RNA-seq; TCR-crosslinking; acute and chronic T cell activation; cytotoxic T cells; immunotherapy; lymphocytic choriomeningitis virus; melanoma; thrombospondin-1

Mesh:

Substances:

Year:  2022        PMID: 36105746      PMCID: PMC9467551          DOI: 10.1080/2162402X.2022.2111909

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   7.723


  108 in total

1.  Cutting edge: CD47 controls the in vivo proliferation and homeostasis of peripheral CD4+ CD25+ Foxp3+ regulatory T cells that express CD103.

Authors:  Vu Quang Van; Jinane Darwiche; Marianne Raymond; Sylvie Lesage; Salim Bouguermouh; Manuel Rubio; Marika Sarfati
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

Review 2.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

3.  Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

Authors:  Enrico M Novelli; Lynda Little-Ihrig; Heather E Knupp; Natasha M Rogers; Mingyi Yao; Jeffrey J Baust; Daniel Meijles; Claudette M St Croix; Mark A Ross; Patrick J Pagano; Evan R DeVallance; George Miles; Karin P Potoka; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

4.  Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation.

Authors:  Z Li; L He; K Wilson; D Roberts
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

5.  TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.

Authors:  Penka S Petrova; Natasja Nielsen Viller; Mark Wong; Xinli Pang; Gloria H Y Lin; Karen Dodge; Vien Chai; Hui Chen; Vivian Lee; Violetta House; Noel T Vigo; Debbie Jin; Tapfuma Mutukura; Marilyse Charbonneau; Tran Truong; Stephane Viau; Lisa D Johnson; Emma Linderoth; Eric L Sievers; Saman Maleki Vareki; Rene Figueredo; Macarena Pampillo; James Koropatnick; Suzanne Trudel; Nathan Mbong; Liqing Jin; Jean C Y Wang; Robert A Uger
Journal:  Clin Cancer Res       Date:  2016-11-17       Impact factor: 12.531

6.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

7.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

8.  Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.

Authors:  Travis A Doering; Alison Crawford; Jill M Angelosanto; Michael A Paley; Carly G Ziegler; E John Wherry
Journal:  Immunity       Date:  2012-11-15       Impact factor: 31.745

9.  CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis.

Authors:  Laurence Lamy; Michel Ticchioni; Alexandre K Rouquette-Jazdanian; Michel Samson; Marcel Deckert; Arnold H Greenberg; Alain Bernard
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

10.  CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis.

Authors:  Dhammika H M L P Navarathna; Erica V Stein; Elizabeth C Lessey-Morillon; Debasis Nayak; Gema Martin-Manso; David D Roberts
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.